Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007
Dopamine Agonists and the Risk of Cardiac Valve Regurgitation
NEJM 356:29-38, Schade,R.,et al, 2007
Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005
Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease
Lancet 363:1179-1183, Van Camp,G.,et al, 2004
Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003
Multiple Intracerebral Hemorrhages and Vasospasm Following Antimigrainous Drug Abuse
Headache 38:478-480, Nighoghossian,N.,et al, 1998
Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations
Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992
Pleural and Retroperitoneal Fibrosis from Dihydroergotamine
NEJM 321:1760, Malaquin,F.,et al, 1989
Bilateral Focal Cortical Atrophy & Chronic Ergotamine Abuse
Neurol 35:720-722, Fincham,R.W.,et al, 1985
Carotidynia
Neurol 27:43, Raskin,N.H.,et al, 1977
Transient Monocular Blindness
Aspects of Neuro-Opthal, ed. by S. I. Davidson, 1974. , p. 103., Hutchinson,E.C., 1974